Company Filing History:
Years Active: 2015-2016
Title: Innovations of Zhimin Ji in Cancer Treatment
Introduction
Zhimin Ji is a notable inventor based in Palo Alto, California, recognized for his contributions to the field of cancer treatment. With a focus on developing innovative therapies, he has been instrumental in advancing medical science through his patented inventions.
Latest Patents
Zhimin Ji holds two significant patents related to Jagged-binding agents. His latest inventions include methods for treating diseases such as cancer by utilizing antibodies that specifically bind to the extracellular domains of human Jagged1 and Jagged2. These antibodies modulate Jagged activity, providing a novel approach to inhibit tumor growth. The patents describe methods for administering therapeutically effective amounts of these agents to patients suffering from tumors or cancer, showcasing Ji's commitment to improving cancer treatment options.
Career Highlights
Zhimin Ji is currently associated with Oncomed Pharmaceuticals, Inc., where he continues to work on groundbreaking research in oncology. His expertise in developing targeted therapies has positioned him as a key figure in the pharmaceutical industry, contributing to advancements that may significantly impact patient outcomes.
Collaborations
Zhimin Ji collaborates with esteemed colleagues such as Austin L. Gurney and Timothy Charles Hoey. Their combined efforts in research and development have fostered an environment of innovation, leading to the creation of effective cancer therapies.
Conclusion
Zhimin Ji's work exemplifies the intersection of innovation and medical science, particularly in the fight against cancer. His patents and ongoing research efforts reflect a dedication to improving therapeutic strategies for patients.